Transforming Growth Factor-β1 Increases Bad Phosphorylation and Protects Neurons Against Damage

Journal of Neuroscience

Volumn 22, Issue 10, 2002, Pages 3898-3909

  Zhu, Yuan ^a   Yang, Guo Yuan ^b   Ahlemeyer, Barbara ^a   Pang, Li ^b   Che, Xiao Ming ^b   Culmsee, Carsten ^a   Klumpp, Susanne ^a   Krieglstein, Josef ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Bad phosphorylation; Cerebral ischemia; MAPK Erk signaling; Neuroprotection; Rat hippocampal cells; TGF 1

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; CASPASE 3; DNA FRAGMENT; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN BAD; SERINE DERIVATIVE; STAUROSPORINE; TRANSFORMING GROWTH FACTOR BETA1; UO 126; BAD PROTEIN, MOUSE; CARRIER PROTEIN; CASP3 PROTEIN, HUMAN; CASP3 PROTEIN, MOUSE; CASP3 PROTEIN, RAT; CASPASE; ENZYME INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUROPROTECTIVE AGENT; RPS6KA1 PROTEIN, MOUSE; RPS6KA1 PROTEIN, RAT; S6 KINASE; TGFB1 PROTEIN, HUMAN; TGFB1 PROTEIN, MOUSE; TGFB1 PROTEIN, RAT; TRANSFORMING GROWTH FACTOR BETA;

ADENOVIRUS; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; BRAIN SLICE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; FRAGMENTATION REACTION; HIPPOCAMPUS; MOUSE; NERVE CELL CULTURE; NERVE INJURY; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; CEREBRAL ARTERY DISEASE; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION; GENETIC TRANSDUCTION; GENETICS; MALE; METABOLISM; NERVE CELL; PHYSIOLOGY; TRANSIENT ISCHEMIC ATTACK;

ANIMALS; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; CARRIER PROTEINS; CASPASE 3; CASPASES; CELLS, CULTURED; ENZYME ACTIVATION; ENZYME INHIBITORS; GENE EXPRESSION; HIPPOCAMPUS; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC ATTACK, TRANSIENT; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NEURONS; NEUROPROTECTIVE AGENTS; PHOSPHORYLATION; RIBOSOMAL PROTEIN S6 KINASES; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SIGNAL TRANSDUCTION; TRANSDUCTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0037095746     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-10-03898.2002     Document Type: Article

References (55)

1. Abe K, Aoyagi A, Saito H (2001) Sustained phosphorylation of mitogen-activated protein kinase is required for basic fibroblast growth factor-mediated axonal branch formation in cultured rat hippocampal neurons. Neurochem Int 38:309-315.
2. Alessandrini A, Namura S, Moskowitz MA, Bonventre J (1999) MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proc Natl Acad Sci USA 96:12866-12869.
3. Anderson CNG, Tolkovsky AM (1999) A role for MAPK/ERK in sympathetic neuron survival: protection against a p53-dependent, JUK-independent induction of apoptosis by cytosine arabinoside. J Neurosci 19:664-673.
4. Aronowski J, Samways E, Strong R, Rhoades HM, Grotta JC (1996) An alternative method for the quantitation of neuronal damage after experimental middle cerebral artery occlusion in rats: analysis of behavioral deficit. J Cereb Blood Flow Metab 16:705-713.
5. Arrick BA, Lopez AR, Elfman R, Damsky CH, Derynck R (1992) Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor beta 1. J Cell Biol 118:715-726.
6. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME (1999) Cell survival promoted by the Ras-MAPK signalling pathway by transcription-dependent and -independent mechanisms. Science 286:1358-1362.
7. Buisson A, Nicole O, Docagne F, Sartelet H, MacKenzie ET, Vivien D (1998) Up-regulation of a serine-protease inhibitor (PAI-1) in astrocytes mediates the neuroprotective activity of transforming growth factor-β1 (TGF-β1). FASEB J 12:1683-1691.
8. Chang L, Karin M (2001) Mammalian MAP kinase signalling cascades. Nature 410:37-40.
9. Chang NS (2000) TGF-β-induced matrix proteins inhibit p42/44 MAPK and JUK activation and suppress TNF-mediated IκBα degradation and NF-κB nuclear transduction in L929 fibroblasts. Biochem Biophys Res Commun 267:194-200.
10. Chen J, Nagayama T, Jin K, Statler RA, Zhu RL, Graham SH, Simon RP (1998) Induction of caspase-3 like protease may mediate delayed neuronal death in the hippocampus after transient forebrain ischemia. J Neurosci 18:4914-4928.
11. Chin BY, Petrache I, Chio AMK, Chio ME (1999) Transforming growth factor-betal rescues serum deprivation-induced apoptosis via MAPK pathway in macrophages. J Biol Chem 274:11362-11368.
12. Chio ME (2000) Mechanism of transforming growth factor-beta1 signalling: role of the mitogen-activated protein kinase. Kidney Int 58:53-58.
13. De Luca A, Weller M, Fontana A (1996) TGF-β-induced apoptosis of cerebellar granule neurons is prevented by depolarization. J Neurosci 16:4174-4185.
14. Downward J (1999) How Bad phosphorylation is good for survival. Nature 1:33-35.
15. Dramsi S, Scheid MP, Maiti A, Hojabrpour P, Chen X, Schubert K, Goodlett DR, Aebersold R, Duronio V (2002) Identification of a novel phosphorylation site, Ser170, as a regulator of Bad pro-apoptotic activity. J Biol Chem 277:6399-6405.
16. Fang X, Yu S, Eder A, Mao M, Bast RC, Boyd D, Mills GB (1999) Regulation of Bad phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway. Oncology 18:6635-6640.
17. Flanders KC, Ren RF, Lippa CF (1998) Transforming growth factor-betas in neurodegenerative diseases. Prog Neurobiol 54:71-85.
18. Gardner AM, Johnson GL (1996) Fibroblast growth factor-2 suppression of tumor necrosis factor alpha-mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase. J Biol Chem 271:14560-14566.
19. Gleichmann M, Weller M, Schulz JB (2000) Insulin-like growth factor-mediated protection from neuronal apoptosis is linked to phosphorylation of the pro-apoptotic protein Bad but not to inhibition of cytochrome c translocation in rat cerebellar neurons. Neurosci Lett 282:69-72.
20. ras/extracellular regulated kinase in neuronal ischemic preconditioning. Proc Natl Acad Sci USA 97:436-441.
21. Han BH, Holtzman DM (2000) BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the Erk pathway. J Neurosci 20:5775-5781.
22. Henrich-Noack P, Prehn JHM, Krieglstein J (1996) TGF-β1 protects hippocampal neurons against degeneration caused by transient global ischemia: dose-response relationship and potential neuroprotective mechanisms. Stroke 27:1609-1615.
23. Hetman M, Kanning AK, Cavanaugh JE, Xia ZG (1999) Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J Biol Chem 274:22569-22580.
24. Hsu SY, Kaipia A, Zhu L, Hsueh AJW (1997) Interference of Bad (Bcl-xl/Bcl-2-associated death promoter)-induced apoptosis in mammalian cells by 14-3-3 isoforms and p11. Mol Endocrinol 11:1858-1867.
25. Klöcker N, Kermer P, Weishaupt JH, Labes M, Ankerhold R, Bähr M (2000) Brain-derived neurotrophic factor-mediated neuroprotection of adult rat retinal ganglion cells in vivo does not exclusively depend on phosphatidyl-inositol-3′-kinase/protein kinase B signalling. J Neurosci 20:6962-6967.
26. Krieglstein K, Krieglstein J (1997) Transforming growth factor-β signalling and neuroprotection. In: Neuroprotective signal transduction (Mattson MP, ed), pp 119-144. Totawa, NJ: Humana.
27. Krieglstein K, Richter S, Farkas L, Schuster N, Drinker N, Oppenheim R, Unsicker K (2000) Reduction of endogenous transforming growth factors β prevents ontogenetic neuron death. Nat Neurosci 3:1085-1090.
28. Lee JM, Zipfel GJ, Choi DW (1999) The changing landscape of ischemic brain injury mechanisms. Nat Neurosci Rev 399:7-14.
29. Ca channels by TGF-β1: transcriptional and posttranscriptional effects mediated by Erk MAP kinase. J Neurosci 20:5616-5622.
30. Lizcano JM, Morrice N, Cohen P (2000) Regulation of Bad by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155. Biochem J 349:547-557.
31. Massagué J (2000) How cells read TGF-β signals. Nature Mol Cell Biol 1:169-178.
32. McCubrey J, May WS, Duronio V, Mufson A (2000) Serine/threonine phosphorylation in cytokine signal transduction. Leukemia 14:9-21.
33. Mulder KM (2000) Role of Ras and MAPKs in TGF-β signalling. Cytokine Growth Factor Rev 11:23-35.
34. Namura S, Lihara K, Takami S, Nagata I, Kikuchi H, Matsushita K, Moskowitz MA, Bonventre JV, Alessandrini A (2001) Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia. Proc Natl Acad Sci USA 98:11569-11574.
35. Nicole O, Ali C, Docagne F, Plawinski L, MacKenzie ET, Vivien D, Buisson A (2001) Neuroprotection mediated by glial cell line-derived neurotrophic factor: Involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein kinase pathway. J Neurosci 21:3024-3033.
36. Pang L, Wen Y, Che XM, Roessler BJ, Betz AL, Yang GY (2001) Reduction of inflammatory response in the mouse brain with adenoviral-mediated transforming growth factor-β1 expression. Stroke 32:544-552.
37. Parrizas M, Saltiel AR, LeRoith D (1997) Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways. J Biol Chem 272:154-161.
38. Prehn JHM, Bindokas VP, Marcuccilli CJ, Krajewski D, Reed JC, Miller RJ (1994) Regulation of neuronal Bcl-2 protein expression and calcium homeostasis by transforming growth factor type β confers wide-ranging protection on rat hippocampal neurons. Proc Natl Acad Sci USA 91:12599-12603.
39. Reimann T, Hempel U, Krautwald S Axmann A, Scheibe R, Seidel D, Wenzel KW (1997) Transforming growth factor-beta1 induces activation of Ras, Raf-1, MEK and MAPK in rat hepatic stellate cells. FEBS Lett 403:57-60.
40. Ruocco A, Nicole O, Docagne F, Ali C, Chazalviel L, Komesli S, Yablonsky F, Roussel S, MacKenzie ET, Vivien D, Buisson A (1999) A transforming growth factor-beta antagonist unmasks the neuroprotective role of this endogenous cytokine in excitotoxic and ischemic brain injury. J Cereb Blood Flow Metab 19:1345-1353.
41. Scheid MP, Schubert KM, Duronio V (1999) Regulation of Bad phosphorylation and association with Bcl-xl by the MAPK/Erk kinase. J Biol Chem 274:31108-31113.
42. Schulz JB, Weller M, Moskowitz MA (1999) Caspases as treatment targets in stroke and neurodegenerative diseases. Ann Neurol 45:421-429.
43. Shimamura A, Ballif BA, Richards SA, Blenis J (2000) Rsk1 mediates a MEK-MAP kinase cell survival signal. Curr Biol 10:127-135.
44. Sugino T, Nozaki K, Takagi Y, Hattori I, Hashimoto N, Moriguchi T, Nishida E (2000) Activation of mitogen-activated protein kinases after transient forebrain ischemia in gerbil hippocampus. J Neurosci 20:4506-4514.
45. Sweatt JD (2001) The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J Neurochem 76:1-10.
46. Unsicker K, Strelau J (2000) Functions of transforming growth factor-β isoforms in the nervous system. Eur J Biochem 267:6972-6975.
47. Virdee K, Parone PA, Tolkovsky AM (2000) Phosphorylation of the pro-apoptotic protein Bad on serine 155, a novel site, contributes to cell survival. Curr Biol 10:1151-1154.
48. Wakefield LM, Winokur TS, Hollands RS, Christopherson K, Levinson AD, Sporn MB (1990) Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution. J Clin Invest 86:1976-1984.
49. Wu DC, Ye W, Che XM, Yang GY (2000) Activation of mitogen-activated protein kinase after permanent cerebral artery occlusion in mouse brain. J Cereb Blood Flow Metab 20:1320-1330.
50. Yang GY, Betz AL, Chenevert TL, Brunberg JA, Hoff JT (1994) Experimental intracerebral hemorrhage: relationship between brain edema, blood flow and blood brain barrier permeability in rats. J Neurosurg 81:93-102.
51. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ (1995) Bad, a heterodimeric partner for Bcl-xl and Bcl-2, displaces Bax and promotes cell death. Cell 80:285-291.
52. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ (1996) Serine phosphorylation of death agonist Bad in response to survival factor results in binding to 14-3-3 not Bcl-xl. Cell 87:619-628.
53. Zhou XM, Liu Y, Payne G, Lutz RJ, Chittenden T (2000) Growth factors inactivate the cell death protein Bad by phosphorylation of its BH3 domain on Ser155. J Biol Chem 275:25046-25051.
54. Zhu Y, Culmsee C, Semkova I, Krieglstein J (1998) Stimulation of β2-adrenoceptors inhibits apoptosis in rat brain after transient forebrain ischemia. J Cereb Blood Flow Metab 18:1032-1039.
55. Zhu Y, Ahlemeyer B, Bauerbach E, Krieglstein J (2001) TGF-β1 prevents neuronal apoptosis in rat hippocampal cultures involving inhibition of caspase-3 activation. Neurochem Int 38:227-235.